Key terms
About FBRX
Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest FBRX news
FBRX Financials
Key terms
Ad Feedback
FBRX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
FBRX Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range